EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
2.7.10.2 | additional information | Tyk2 mutations are associated with autosomal recessive hyperimmunoglobulin E or JobÂ’s syndrome | Homo sapiens |
2.7.10.2 | V617F | JAK2 gain-of-function mutation underlying myeloproliferative diseases | Mus musculus |
2.7.10.2 | V617F | JAK2 gain-of-function mutation underlying myeloproliferative diseases | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.10.2 | CP-690,550 | has nanomolar potency in in vitro JAK2 and JAK3 kinase assays | Homo sapiens | |
2.7.10.2 | CP-690,550 | has nanomolar potency in in vitro JAK2 and JAK3 kinase assays | Mus musculus | |
2.7.10.2 | INCB18424 | Incyte | Homo sapiens | |
2.7.10.2 | INCB18424 | Incyte | Mus musculus | |
2.7.10.2 | XL019 | Exelixis | Homo sapiens | |
2.7.10.2 | XL019 | Exelixis | Mus musculus |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.7.10.2 | Mg2+ | required for activity | Mus musculus | |
2.7.10.2 | Mg2+ | required for activity | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.10.2 | ATP + a [protein]-L-tyrosine | Mus musculus | - |
ADP + a [protein]-L-tyrosine phosphate | - |
? | |
2.7.10.2 | ATP + a [protein]-L-tyrosine | Homo sapiens | - |
ADP + a [protein]-L-tyrosine phosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.10.2 | Homo sapiens | - |
- |
- |
2.7.10.2 | Mus musculus | - |
- |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
2.7.10.2 | phosphoprotein | Y785 and Y813 in JAK3 and JAK2 respectively are prominent sites of autophosphorylation | Mus musculus |
2.7.10.2 | phosphoprotein | Y785 and Y813 in JAK3 and JAK2 respectively are prominent sites of autophosphorylation | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.10.2 | ATP + a [protein]-L-tyrosine | - |
Mus musculus | ADP + a [protein]-L-tyrosine phosphate | - |
? | |
2.7.10.2 | ATP + a [protein]-L-tyrosine | - |
Homo sapiens | ADP + a [protein]-L-tyrosine phosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.10.2 | JAK2 | - |
Mus musculus |
2.7.10.2 | JAK2 | - |
Homo sapiens |
2.7.10.2 | Jak3 | - |
Mus musculus |
2.7.10.2 | Jak3 | - |
Homo sapiens |
2.7.10.2 | Janus kinase | - |
Mus musculus |
2.7.10.2 | Janus kinase | - |
Homo sapiens |
2.7.10.2 | Tyk2 | - |
Mus musculus |
2.7.10.2 | Tyk2 | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.7.10.2 | ATP | - |
Mus musculus | |
2.7.10.2 | ATP | - |
Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.10.2 | malfunction | mutations of JAK3 may be a cause of severe combined immunodeficiency | Homo sapiens |
2.7.10.2 | malfunction | mutations of JAK3 may be a cause of severe combined immunodeficiency, JAK3 knockout mice have a profound reduction in thymic progenitor cells and reduced ability to reconstitute T cell development, in the periphery, CD8+ T and NK cells are severely reduced. JAK3- (and gamma chain) deficient mice also have severely defective B cell development, deficiency of JAK1 and JAK2 is lethal | Mus musculus |
2.7.10.2 | physiological function | JAK3 associates with the common gamma chain cytokine receptor, Tyk2 is involved in signaling by type I interferons, interleukin-12 and interleukin-23 | Mus musculus |
2.7.10.2 | physiological function | JAK3 associates with the common gamma chain cytokine receptor, Tyk2 is involved in signaling by type I interferons, interleukin-12 and interleukin-23 | Homo sapiens |